Molecular Advancements in Tropical Diseases Drug Discovery

Molecular Advancements in Tropical Diseases Drug Discovery presents in-depth knowledge relating to the detection of infection, epidemiology, drugs against various tropical diseases, new target sites for drug discovery and multidrug resistance issues using bioinformatics tools and approaches. The book's chapters are written by experts in their respective fields so that each disease is covered in a rational manner and with a solid foundation on existing facts and prospective research ideas. Updates knowledge about tropical diseases with recent advancements in the field Presents an overview of new research covering detection, infection, epidemiology and risk factors of the most common tropical diseases using bioinformatics tools Encompasses a detailed description of developments in drug discovery, new drugs and their molecular mechanisms of action

Explore novel drug discovery updates from medicinal plants to help fight the devastating effects of neglected tropical diseases Neglected Tropical Diseases and Phytochemicals in Drug Discovery delivers a comprehensive exploration of the drug discovery process as it pertains to neglected tropical diseases. The book covers recent advancements in drug discovery, as well as druggable targets and new challenges facing the industry. It offers readers expansive discussions of specific diseases, including protozoan, helminth, bacterial, viral, fungal, and ectoparasitic infections. This book provides readers with insightful perspectives from leading industry voices on fifty years of trends and progress in the search for new, safe, and affordable therapeutic drugs in the fight against neglected tropical diseases. It includes information beneficial to researchers in a variety of fields of biology, chemistry, medicine, and pharmaceuticals. The distinguished authors cover topics including the effects of phytochemicals on the causative agent of leprosy and the potential applicability of phytochemicals in the management of Dengue fever. Readers will also enjoy the inclusion of: Thorough introductions to neglected tropical diseases, phytochemicals, protein targets, and mechanisms in drug discovery, as well as the epidemiology of neglected tropical diseases An exploration of novel bioactive lead compounds for drug discovery against neglected tropical diseases, leishmaniasis, lymphatic filariasis, trypanosomiasis, and schistosomiasis Discussions of protozoan infections, including herbal, nutritional, and traditional remedies for giardiasis and the anti-leishmanial potentials of phytochemicals Examinations of helminth infections, including the prospects of phytochemicals in the treatment of helminthiasis Perfect for medicinal chemists, drug developers, and research and development scientists, Neglected Tropical Diseases and Phytochemicals in Drug Discovery will also earn a place in the libraries of toxicologists and researchers in biology, chemistry, medicinal chemistry, ethnobotany, and bioinformatics seeking a one-stop resource for drug discovery for neglected tropical diseases.

Malaria is one of the most important tropical diseases in the history of the world. This vector-borne disease has been a significant cause of morbidity and mortality in tropical countries of Africa, Asia, and Latin America. As such, this book provides updated information on epidemiological and public health research of malaria conducted in the last decade. Over four sections, chapters discuss such topics as diagnosis, epidemiology and surveillance, policy and prevention, and vector control and vaccines.

Phenotypic drug discovery has been highlighted in the past decade as an important strategy in the discovery of new medical entities. How many marketed drugs are derived from phenotypic screens? From the most recent examples, what were the factors enabling target identification and validation? This book answers these questions by elaborating on fundamental capabilities required for phenotypic drug discovery and using case studies to illustrate approaches and key success factors. Written and edited by experienced practitioners from both industry and academia, this publication will equip researchers with a thought-provoking guide to the application and future development of contemporary phenotypic drug discovery for clinical success.

Design of Hybrid Molecules for Drug Development reviews the principles, advantages, and limitations involved with designing these groundbreaking compounds. Beginning with an introduction to hybrid molecule design and background as to their need, the book goes on to explore a range of important hybrids, with hybrids containing natural products, molecules containing NO- and H2S-donors, dual-acting compounds acting as receptor ligands and enzyme inhibitors, and the design of photoresponsive drugs all discussed. Drawing on practical case studies, the hybridization of molecules for development as treatments for a number of key diseases is then outlined, including the design of hybrids for Alzheimer's, cancer, and malaria. With its cutting-edge reviews of breaking developments in this exciting field, the book offers a novel approach for all those working in the design, development, and administration of drugs for a range of debilitating disorders. Highlights an approach unimpaired by the limitations of the classical search for lead structures - one of the core problems in modern drug development processes, making the content of high relevance for both academic and non-academic drug development processes Pulls together research and design techniques in a novel way to give researchers the best possible platform from which to review the approaches and techniques applied Compares the advantages and disadvantages of these compounds Includes the very latest developments, such as photoactivatable and photo-responsive drugs

Advances in Cell and Molecular Diagnostics brings the scientific advances in the translation and validation of cellular and molecular discoveries in medicine into the clinical diagnostic setting. It enumerates the description and application of technological advances in the field of cellular and molecular diagnostic medicine, providing an overview of specialized fields, such as biomarker, genetic marker, screening, DNA-profiling, NGS, cytogenetics, transcriptome, cancer biomarkers, prostate specific antigen, and biomarker toxicologies. In addition, it presents novel discoveries and clinical pathologic correlations, including studies in oncology, infectious diseases, inherited diseases, predisposition to disease, and the description or polymorphisms linked to disease states. This book is a valuable resource for oncologists, practitioners and several members of the biomedical field who are interested in understanding how to apply cutting-edge technologies into diagnostics and healthcare. Encompasses the current scientific advances in the translation and validation of cellular and molecular discoveries into the clinical diagnostic setting Explains the application of cellular and molecular diagnostics methodologies in clinical trials Focuses on translating preclinical tests to the bedside in order to help readers apply the most recent technologies to healthcare

Biomedical advances have made it possible to identify and manipulate features of living organisms in useful ways--leading to improvements in public health, agriculture, and other areas. The globalization of scientific and technical expertise also means that many scientists and other individuals around the world are generating breakthroughs in the life sciences and related technologies. The risks posed by bioterrorism and the proliferation of biological weapons capabilities have increased concern about how the rapid advances in genetic engineering and biotechnology could enable the production of biological weapons with unique and unpredictable characteristics. Globalization, Biosecurity, and the Future of Life Sciences examines current trends and future objectives of research in public health, life sciences, and biomedical science that contain applications relevant to developments in biological weapons 5 to 10 years into the future and ways to anticipate, identify, and mitigate these dangers.

Medicinal Chemistry of Neglected and Tropical Diseases: Advances in the Design and Synthesis of Antimicrobial Agents consolidates and describes modern drug discovery and development approaches currently employed to identify effective chemotherapeutic agents for the treatment of Neglected Tropical Diseases (NTDs) from a medicinal chemistry perspective. Chapters are designed to cater to the needs of medicinal chemists who work with chemotherapeutic developments for NTDs, as well as serve as a guide to budding medicinal chemists who wish to work in this area. It will introduce rational drug design approaches adopted in designing chemotherapeutics and validated targets available for the purpose.

This book reviews the advances and challenges of structure-based drug design in the preclinical drug discovery process, addressing various diseases, including malaria, tuberculosis and cancer. Written by internationally recognized researchers, this edited book discusses how the application of the various in-silico techniques, such as molecular docking, virtual screening, pharmacophore modeling, molecular dynamics simulations, and residue interaction networks offers insights into pharmacologically active novel molecular entities. It presents a clear concept of the molecular mechanism of different drug targets and explores methods to help understand drug resistance. In addition, it includes chapters dedicated to natural-product- derived medicines, combinatorial drug discovery, the CryoEM technique for structure-based drug design and big data in drug discovery. The book offers an invaluable resource for graduate and postgraduate students, as well as for researchers in academic and industrial laboratories working in the areas of chemoinformatics, medicinal and pharmaceutical chemistry and pharmacoinformatics.

The process of drug discovery and development is a complex multistage logistics project spanned over 10-15 years with an average budget exceeding 1 billion USD. Starting with target identification and synthesizing anywhere between 10k to 15k synthetic compounds to potentially obtain the final drug that reaches the market involves a complicated maze with multiple inter- and intra-operative fields. Topics described in this book emphasize the progresses in computational applications, pharmacokinetics advances, and molecular modeling developments. In addition the book also contains special topics describing target deorphaning in Mycobacterium tuberculosis, therapy treatment of some rare diseases, and developments in the pediatric drug discovery process.

Drug repurposing or drug repositioning is a new approach to presenting new indications for common commercial and clinically approved existing drugs. For example, chloroquine, an old antimalarial drug, showed promising results for treating COVID-19, interfering with MDR in several types of cancer, and chemosensitizing human leukemic cells.This book focuses on the hypothesis, risk/benefits, and economic impacts of drug repurposing on drug discovery in dermatology, infectious diseases, neurological disorders, cancer, and orphan diseases. It brings together up-to-date research to provide readers with an informative, illustrative, and easy-to-read book useful for students, clinicians, and the pharmaceutical industry.

March 20-21, 2017 Rome, Italy Key Topics : Immuno Genetics & Histocompatibility, Molecular Immunology, Cellular Immunology, Tumor Immunology, Auto Immune Diseases, Vaccinology, Haematopoietic and Lymphoid Malignancies, Immunoproliferative disorders, Paediatric Immunology, Immunodermatology, Osteoimmunology, Immunohaematology, Transplantation Immunology, Cellular Therapy, Immunological Techniques, Microbial Immunology, Industrial Immunology, Computational Immunology, Cancer Immunology, Biochemistry and Molecular Biology, Molecular Medicine, Clinical and Molecular Allergy, Molecular Biomarker, Molecular & Cellular Oncology,

Nov 06-08, 2017 Frankfurt, Germany Key Topics : Nanomedicine & Nanobiotechnology,Nanoparticles, Nanomaterials- production, synthesis and processing, Nanoengineering, Computation, Simulation & Modeling of Nanostructures, Nano systems & devices, Bio-Nanomaterials and biomedical devices, applications, Nano photonics, Nano Imaging, Spectroscopy & Plasmonic devices, Nanoelectronics and nanometrology, Nanotechnology & Energy, Micro/ Nano-fabrication, Nano patterning, Nano Lithography & Nano Imprinting, Nanotechnology: Environmental effects and Industrial safety, Future prospects of Nanotechnologies and commercial viability, Graphene and Applications, Other Related research, Dna Nanoelectronics,

It is very important for scientists all over the globe to enhance drug discovery research for better human health. This book demonstrates that various expertise are essential for drug discovery including synthetic or natural drugs, clinical pharmacology, receptor identification, drug metabolism, pharmacodynamic and pharmacokinetic research. The following 5 sections cover diverse chapter topics in drug discovery: Natural Products as Sources of Leading Molecules in Drug Discovery; Oncology and Drug Discovery; Receptors Involvement in Drug Discovery; Management and Development of Drugs against Infectious Diseases; Advanced Methodology.

November 16-17, 2017 Paris, France key Topics : Chemical engineering, Catalysis Engineering, Biologically Engineered Systems, Bio Fuels, Biotechnology, Biomaterials, Water Technology and Innovation, Polymer Technology, Thermodynamic Process, Seperation Techniques, Biochemical Engineering, Transport Phenomenon, Fluid Dynamics, Chemical reaction Engineering, Petroleum Engineering, Safety Methods, Enterpreneurship Investment Meet, Carbon and Graphene Materials, Environmental Engineering,

July 13-14, 2017 Berlin, Germany Key Topics : Major Chromatographic Techniques, HPLC Separation Techniques, Advances in HPLC Instrumentations, Hyphenated HPLC Methods, Chip Based Separations, High Efficiency and High Resolution Techniques, Method Development and Validation, Applications of HPLC, Biochemical Applications, HPLC Fingerprinting in Bioinformatics and Computational Biology, Recent Advances in HPLC, Market growth of HPLC

June 07-08, 2017 Milan,. Italy Key Topics : Medicinal Chemistry, Synthetic Organic Chemistry, Drug Design and Drug Development, CADD (Computer Aided Drug Design), Bioorganic and Medicinal Chemistry, Pharmacology and toxicology, BioInorganic Chemistry, Organometallic Chemistry, Radiopharmaceuticals, Chemical Biology, Anticancer agents in Medicinal Chemistry, Pharmaceutical Industry, Clinical Pharmacology, Pharmaceutical Sciences, Bioisostere, Analytical Chemistry, Nanomedicine, Stereochemistry, Pharmacovigilance,

May 11-12, 2017 Barcelona, Spain Key Topics : Infection and Immune System, Host and Microbial Genetics, Infections from Contaminated Pharmaceuticals or Counterfeit Medications, Foodborne & Waterborne Illnesses, Nosocomial Infections, Pediatric Infections, Emergence and Pathogenesis of Coronaviruses, Hemorrhagic Fevers, New or Rapid Diagnostics, Therapeutic Interventions in Rare Diseases, Antimicrobial Resistance, Drug metabolism in microorganisms, Infection Control and Epidemiology, New Opportunities for Tuberculosis Control,

September 07-09, 2017 Paris, France Key Topics : Viral Infectious Diseases, Bacterial Infectious Diseases, Ebola Outbreak and Approaches for Prevention, Fungal Infectious Diseases, New Antiviral, Antibacterial and Antifungal Agents, Market Trends Of Infectious Diseases, Parasitic Diseases, Bacterial Susceptibility & Resistance, Nosocomial Infections, Detection and preventing infections in healthcare, Public health practice, Vaccines, Respiratory Diseases, Infectious Agents and the Human Immune Response, Infectious Diseases: Worms, Prions, and Fungi, Protozoal Diseases, Clinical Infectious Disease, Infectious Disease Epidemiology, Emerging Infectious Diseases, Laboratory Diagnosis of Infectious Diseases, Infectious Diseases of Humans, Infectious Diseases and Pathology, Microbiology and Infectious Diseases, Infectious Diseases of Livestock, Infectious Diseases of the Female Genital Tract, Molecular Diagnostics of Infectious Diseases, Pediatric Infectious Diseases, Bacterial Genomes and Infectious Diseases:, Drug Interactions in Infectious Diseases, Infectious Diseases in Children, Medical Pioneers in Infectious Diseases, Infectious Diseases and Tropical Medicine, Infectious Diseases in Critical Care Medicine, Infectious Diseases and Arthropods, Preventing Infectious Diseases, Feline Infectious Diseases, Tropical Infectious Diseases, Infectious Diseases in America, Infectious Diseases in Europe, Infectious Diseases in UK, Infectious Diseases in Asia, Infectious Diseases in Africa, Sexually transmitted Diseases and infection,